Business Standard

Friday, December 20, 2024 | 01:07 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Cadila to produce up to 30 mn coronavirus vaccine doses a month: MD

The virus has killed nearly 100,000 Indians in May alone

Glaxo and Sanofi plan to start advanced trials in coming weeks, with multiple formulations of the vaccine to better protect against variants. (Photo: Bloomberg)
Premium

Representational image

Reuters
India's Cadila Healthcare is aiming to triple monthly production of a COVID-19 vaccine candidate to as many as 30 million doses, its managing director said on Monday, as the country battles a massive wave of infections.
 
The virus has killed nearly 100,000 Indians in May alone according to official figures, although experts say actual numbers are likely many times higher. India's COVID-19 death toll surged past 300,000 on Monday, health ministry data showed.
 
India is also facing a shortage of vaccines. Weekly vaccinations have fallen from a peak of nearly 25 million doses in early April to about 9 million.

Disclaimer: No Business Standard Journalist was involved in creation of this content

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in